Navigation Links
Halozyme Therapeutics to Hold Pipeline Update Conference Call on May 9
Date:5/1/2008

Technology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. Its key partnerships are with Roche to apply Enhanze Technology to Roche's biological therapeutic compounds for up to 13 targets and with Baxter to apply Enhanze Technology to Baxter's biological therapeutic compound, GAMMAGARD LIQUID 10%. In addition, the company has received FDA approval for two products: Cumulase(R), for use in in-vitro fertilization, and HYLENEX, for use as an adjuvant to increase the absorption and dispersion of other injected drugs and fluids. HYLENEX is partnered with Baxter International Inc. The Company also has a number of different enzymes in its portfolio that are targeting significant areas of unmet need.

Halozyme Contact

David A. Ramsay

Chief Financial Officer

(858) 704-8260

dramsay@halozyme.com


'/>"/>
SOURCE Halozyme Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results
2. Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences
3. Halozyme Therapeutics to Hold Pipeline Update Conference Call on March 14
4. Halozyme Therapeutics to Present at the BIO CEO and Investor Conference and the Roth Growth Stock Conference
5. Halozyme Therapeutics Amends Stockholder Rights Plan
6. Halozyme Therapeutics Reports 2007 Third Quarter Financial Results
7. Halozyme Therapeutics to Present at UBS 2007 Global Life Sciences Conference
8. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
9. United Therapeutics Reports First Quarter 2008 Financial Results
10. Cell Therapeutics, Inc. Sells $64.5 million Units Consisting of Preferred Stock, New 2014 Convertible Senior Notes and Warrants to a Single Institutional Investor
11. Frederic Desdouits Appointed Member of the Supervisory Board of ExonHit Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... using an electric field (magnetoelectric memory [MEM] effect), ... technology for information processing and storage. Multiferroic materials ... to the coexistence of electric and magnetic orders. ... electric and magnetic polarizations is rare in known ... MEM effect. This article briefly reviews a new ...
(Date:9/12/2014)... Worcester, Mass. (PRWEB) September 12, 2014 ... the detection and decontamination of chemical and biological ... workshop organized by Worcester Polytechnic Institute (WPI) and ... sponsored by the Science for Peace and Security ... , Part of NATO’s Advanced Research Workshop series, ...
(Date:9/12/2014)... CA (PRWEB) September 12, 2014 Today, ... campaign on Indiegogo. , The film, directed by ... Buzz Aldrin, Shimon Peres, Ashton Kutcher, Will.i.Am, Michio Kaku, ... world and there’s only one university in the world ... help change the lives of a billion people: Singularity ...
(Date:9/12/2014)... Albuquerque, NM (PRWEB) September 12, 2014 ... signed an exclusive option agreement with STC.UNM (STC) for ... New Mexico (UNM) in Albuquerque, New Mexico, and Queen ... group of technologies, called the Recombinant Fluorescent Antibody Technology ... UNM’s Department of Internal Medicine and Dr. Angray Kang ...
Breaking Biology Technology:Worcester Polytechnic Institute to Lead Scientific Workshop on Nanoscale Defenses for Biological and Chemical Threats 2Worcester Polytechnic Institute to Lead Scientific Workshop on Nanoscale Defenses for Biological and Chemical Threats 3Documentary Film that Follows Singularity University Students as They Change the World Launches its IndieGoGo Fundraising Campaign 2Sandia Biotech and STC.UNM Announce Option Agreement to License Novel Recombinant Antibody Technology 2Sandia Biotech and STC.UNM Announce Option Agreement to License Novel Recombinant Antibody Technology 3Sandia Biotech and STC.UNM Announce Option Agreement to License Novel Recombinant Antibody Technology 4
... at National Department of Labor Conference, WEST ... the U.S. Department of Labor,s Recognition of Excellence ... Serve Emerging,Industries." Deputy Assistant Secretary of Labor for ... award which honors,workforce investment programs from around the ...
... Inc.,(Nasdaq: BHRT ) a company committed to ... and treat heart failure and,cardiovascular diseases, today announced ... 2008., Recent Clinical Highlights:, -- On ... of a preclinical,study involving the injection of myoblasts ...
... on science education, SAN DIEGO, July 30 ... literacy, has secured non-profit,status and funding for its mission ... science companies., Funded with two initial $30,000 grants ... institute is a 501 (c) (3) arm of BIOCOM, ...
Cached Biology Technology:Workforce Alliance Receives U.S. Labor Department's Excellence Award 2Workforce Alliance Receives U.S. Labor Department's Excellence Award 3Bioheart, Inc. Announces Financial Results for Second Quarter 2008 2Bioheart, Inc. Announces Financial Results for Second Quarter 2008 3Bioheart, Inc. Announces Financial Results for Second Quarter 2008 4Bioheart, Inc. Announces Financial Results for Second Quarter 2008 5Bioheart, Inc. Announces Financial Results for Second Quarter 2008 6Bioheart, Inc. Announces Financial Results for Second Quarter 2008 7BIOCOM Institute Secures Non-Profit Designation and Funding 2BIOCOM Institute Secures Non-Profit Designation and Funding 3
(Date:9/12/2014)... researchers have discovered that cartilage plays an active ... seen in rheumatoid arthritis, rather than being an ... Liu, Professor Ian Wicks, Dr Kate Lawler, Dr ... Eliza Hall Institute made the discovery while investigating ... inflammation during rheumatoid arthritis. The study was published ...
(Date:9/12/2014)... is a serious parasitic infection of young piglets ... diarrhoea and reduced nutritional intake. As the infection ... result in increased mortality, the disease is responsible ... "The developing immune system of neonatal piglets is ... parasites. For this reason, an infection shortly after ...
(Date:9/11/2014)... show a reduced frequency of social interactions and ... behaviors. Autism has also been linked to dysfunction ... processing emotions. Now Caltech researchers have discovered antagonistic ... whether the animal engages in social behaviors or ... for understanding neural circuit dysfunctions that underlie autism ...
Breaking Biology News(10 mins):No innocent bystander: Cartilage contributes to arthritis 2Piglet health 2Piglet health 3Tipping the balance of behavior 2Tipping the balance of behavior 3
... PHILADELPHIA (December 8, 2013) According to Gertrude Stein, "A ... indicates that might not be the case when it comes ... collaborating institutions have found that as much as 30 percent ... any two individuals. This substantial variation is in turn reflected ...
... items to freezing temperatures may be a viable control option ... new study has found that bed bugs may be less ... article in the Journal of Economic Entomology called ... the authors describe how exposing bed bugs to freezing temperatures ...
... ORLEANS, December 7, 2013) Hematopoietic stem cell transplantation ... drug therapy for blood cancer, has become more accessible ... a result of major advances in transplant strategies and ... during the 55th American Society of Hematology Annual Meeting ...
Cached Biology News:Extensive variability in olfactory receptors influences human odor perception 2International gene therapy trial for 'bubble boy' disease shows promising early results 2International gene therapy trial for 'bubble boy' disease shows promising early results 3International gene therapy trial for 'bubble boy' disease shows promising early results 4International gene therapy trial for 'bubble boy' disease shows promising early results 5International gene therapy trial for 'bubble boy' disease shows promising early results 6International gene therapy trial for 'bubble boy' disease shows promising early results 7